ProPhase Labs, Inc. Quarterly report pursuant to Section 13 or 15(d)

Significant Customers (Details Narrative) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Net sales	$ 3,623	$ 1,651	$ 5,511	$ 3,969
Sales Revenue, Net [Member] \| Third Party Contract Manufacturing Customer One [Member]
Concentration risk, percentage	58.70%	67.20%	55.20%	54.80%
Sales Revenue, Net [Member] \| Third Party Contract Manufacturing Customer Two [Member]
Concentration risk, percentage	16.60%	21.10%	17.10%	22.80%
Sales Revenue, Net [Member] \| Third Party Contract Manufacturing Customer Three [Member]
Concentration risk, percentage	12.20%
Trade Receivable [Member] \| Customer One [Member]
Concentration risk, percentage			72.40%		70.00%
Trade Receivable [Member] \| Customer Two [Member]
Concentration risk, percentage			12.80%		14.00%
Trade Receivable [Member] \| Customer Three [Member]
Concentration risk, percentage					11.00%